{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:32:32Z","timestamp":1761708752861},"reference-count":22,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Forensic Science International"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.forsciint.2012.04.009","type":"journal-article","created":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T15:32:40Z","timestamp":1335886360000},"page":"98-101","source":"Crossref","is-referenced-by-count":14,"title":["Estimation of gamma-hydroxybutyrate (GHB) co-consumption in serum samples of drivers positive for amphetamine or ecstasy"],"prefix":"10.1016","volume":"221","author":[{"given":"S.","family":"Lott","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Musshoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Madea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 6","key":"10.1016\/j.forsciint.2012.04.009_bib0005","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1002\/ana.10696","article-title":"GABA, gamma-hydroxybutyric acid, and neurological disease","volume":"54","author":"Wong","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.forsciint.2012.04.009_bib0010","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0741-8329(99)00090-7","article-title":"Abuse and therapeutic potential of gamma-hydroxybutyric acid","volume":"20","author":"Galloway","year":"2000","journal-title":"Alcohol"},{"key":"10.1016\/j.forsciint.2012.04.009_bib0015","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s11940-011-0137-6","article-title":"Recent advances in the treatment of narcolepsy","volume":"13","author":"Hirai","year":"2011","journal-title":"Curr. Treat. Options Neurol."},{"key":"10.1016\/j.forsciint.2012.04.009_bib0020","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.3390\/ijerph6061917","article-title":"Gamma hydroxybutyric acid (GHB) for the treatment of alcohol dependence: a review","volume":"6","author":"Caputo","year":"2009","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.forsciint.2012.04.009_bib0025","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1124\/jpet.109.165381","article-title":"Concentration\u2013effect relationships for the drug of abuse gamma-hydroxybutyric acid","volume":"333","author":"Felmlee","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.forsciint.2012.04.009_bib0030","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/qjmed\/hcm117","article-title":"Medical and legal confusion surrounding gamma-hydroxybutyrate (GHB) and its precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4BD)","volume":"101","author":"Wood","year":"2008","journal-title":"QJM"},{"key":"10.1016\/j.forsciint.2012.04.009_bib0035","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s12024-008-9040-1","article-title":"Driving under the influence of gamma-hydroxybutyrate (GHB)","volume":"4","author":"Jones","year":"2008","journal-title":"Forensic Sci. Med. Pathol."},{"key":"10.1016\/j.forsciint.2012.04.009_bib0040","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/jat\/28.6.512","article-title":"Addicted to driving under the influence\u2014a GHB\/GBL case report","volume":"28","author":"Couper","year":"2004","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2012.04.009_bib0045","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0379-0738(03)00044-6","article-title":"Forensic cases involving the use of GHB in The Netherlands","volume":"133","author":"Bosman","year":"2003","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.forsciint.2012.04.009_bib0050","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1520\/JFS15070J","article-title":"GHB and driving impairment","volume":"46","author":"Couper","year":"2001","journal-title":"J. Forensic Sci."},{"key":"10.1016\/j.forsciint.2012.04.009_bib0055","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.forsciint.2010.03.035","article-title":"Gamma-hydroxybutyrate in urine and serum: additional data supporting current cut-off recommendations","volume":"200","author":"Andresen","year":"2010","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.forsciint.2012.04.009_bib0060","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/jat\/28.8.644","article-title":"A reference range for endogenous gamma-hydroxybutyrate in urine by gas chromatography\u2013mass spectrometry","volume":"28","author":"Crookes","year":"2004","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2012.04.009_bib0065","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S0379-0738(02)00183-4","article-title":"Determination of endogenous gamma-hydroxybutyric acid (GHB) levels in antemortem urine and blood","volume":"128","author":"Elian","year":"2002","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.forsciint.2012.04.009_bib0070","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/jat\/34.9.555","article-title":"Urinary gamma-hydroxybutyrate concentrations in 1126 female subjects","volume":"34","author":"Brailsford","year":"2010","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2012.04.009_bib0075","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.forsciint.2007.02.009","article-title":"Prevalence of gamma-hydroxybutyrate (GHB) in serum samples of amphetamine, metamphetamine and ecstasy impaired drivers","volume":"173","author":"Dresen","year":"2007","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.forsciint.2012.04.009_bib0080","first-page":"5","article-title":"New drugs: ectasy and gamma-hydroxy-butyrate (GHB)","volume":"13","author":"Feldman","year":"2002","journal-title":"Vertex"},{"key":"10.1016\/j.forsciint.2012.04.009_bib0085","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1592\/phco.21.20.1486.34472","article-title":"A comprehensive review of MDMA and GHB: two common club drugs","volume":"21","author":"Teter","year":"2001","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.forsciint.2012.04.009_bib0090","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.forsciint.2006.05.021","article-title":"Validation of new methods","volume":"165","author":"Peters","year":"2007","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.forsciint.2012.04.009_bib0095","first-page":"599","article-title":"Liquid ecstasy\u2014a significant drug problem","volume":"105","author":"Andresen","year":"2008","journal-title":"Dtsch. Arztebl. Int."},{"key":"10.1016\/j.forsciint.2012.04.009_bib0100","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1007\/s00101-004-0723-z","article-title":"gamma-Hydroxybutyrate intoxication","volume":"53","author":"Hahne","year":"2004","journal-title":"Anaesthesist"},{"key":"10.1016\/j.forsciint.2012.04.009_bib0105","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s00228-010-0870-x","article-title":"Blood GHB concentrations and results of medical examinations in 25 car drivers in Norway","volume":"66","author":"Al-Samarraie","year":"2010","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.forsciint.2012.04.009_bib0110","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1093\/jat\/31.9.566","article-title":"Gamma-hydroxybutyrate concentrations in the blood of impaired drivers, users of illicit drugs, and medical examiner cases","volume":"31","author":"Jones","year":"2007","journal-title":"J. Anal. Toxicol."}],"container-title":["Forensic Science International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0379073812001727?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0379073812001727?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,23]],"date-time":"2018-11-23T18:55:04Z","timestamp":1542999304000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0379073812001727"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":22,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S0379073812001727"],"URL":"https:\/\/doi.org\/10.1016\/j.forsciint.2012.04.009","relation":{},"ISSN":["0379-0738"],"issn-type":[{"value":"0379-0738","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}